Pharmaceutical Exports
-
{
- All
- News
- Videos
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India-US Trade Deal Explained: Who Wins, Who Pays And What Stays Protected
Piyush Goyal said government has secured a tariff structure that protects the countrys most sensitive food sectors while unlocking wider export opportunities for Indian manufacturers.
-
India-US Trade Pact To Open $30 Trillion Market For Indian Exporters: Piyush Goyal
The India-US trade pact will open a $30 trillion market for Indian exporters, especially MSMEs, farmers and fishermen, Commerce and Industry Minister Piyush Goyal said.
-
India's Top Export Markets: A Shifting Landscape Explained In Graphics
The United States on Monday slashed tariffs on Indian goods to 18 per cent, down from the previously effective rate of 50 per cent.
-
US Revives Drug Origin Debate, Cites Indian Exports
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India-US Trade Deal Explained: Who Wins, Who Pays And What Stays Protected
Piyush Goyal said government has secured a tariff structure that protects the countrys most sensitive food sectors while unlocking wider export opportunities for Indian manufacturers.
-
India-US Trade Pact To Open $30 Trillion Market For Indian Exporters: Piyush Goyal
The India-US trade pact will open a $30 trillion market for Indian exporters, especially MSMEs, farmers and fishermen, Commerce and Industry Minister Piyush Goyal said.
-
India's Top Export Markets: A Shifting Landscape Explained In Graphics
The United States on Monday slashed tariffs on Indian goods to 18 per cent, down from the previously effective rate of 50 per cent.
-
US Revives Drug Origin Debate, Cites Indian Exports
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
